Fremanezumab adherence & persistence along with past & concomitant migraine medication use: PEARL 3rd interim analysis

被引：0

作者：

Tassorelli, C. ^{[1
,2
]}

Mitsikostas, D. ^{[3
]}

Amin, F. ^{[4
,5
]}

Kokturk, P. ^{[6
]}

Schankin, C. ^{[7
]}

Sahin, G. ^{[8
]}

Pozo-Rosich, P. ^{[9
,10
]}

Dorman, P. ^{[11
]}

Nezadal, T. ^{[12
]}

Poole, A. ^{[13
]}

Martins, I. ^{[14
]}

Sumelahti, M. ^{[15
]}

Krasenbaum, L. ^{[16
]}

Ahn, A. ^{[16
]}

Lyras, L. ^{[6
]}

Ashina, M. ^{[17
,18
]}

机构：

[1] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy

[2] IRCCS Mondino Fdn, Pavia, Italy

[3] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept First Neurol, Athens, Greece

[4] Rigshosp Glostrup, Dept Neurol, Danish Headache Ctr, Copenhagen Univ Hosp, Copenhagen, Denmark

[5] Univ Copenhagen, Dept Neurorehabil Traumat Brain Injury, Rigshosp Glostrup, Copenhagen, Denmark

[6] Teva Netherlands BV, Amsterdam, Netherlands

[7] Univ Bern, Dept Neurol, Inselspital, Univ Hosp Bern, Bern, Switzerland

[8] Lund Univ, Skaneuro Neurol Clin, Dept Clin Sci Lund, Lund, Sweden

[9] Vall dHebron Hosp, Headache Unit & Res Grp, Barcelona, Spain

[10] Univ Autonoma Barcelona, Res Inst, Barcelona, Spain

[11] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle, Australia

[12] Charles Univ Prague, Inst Neuropsychiat Care, Sch Med 1, Prague, Czech Republic

[13] Oslo Headache Ctr, Oslo, Norway

[14] Univ Lisbon, Ctr Estudos Egas Moniz, Fac Med, Lisbon, Portugal

[15] Univ Tampere, Fac Med & Hlth Technol, Pirkanmaa, Finland

[16] Teva Branded Pharmaceut Prod R&D, W Chester, PA USA

[17] Rigshosp Glostrup, Dept Neurol, Danish Headache Ctr, Copenhagen Univ Hosp, Copenhagen, Denmark

[18] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EPO-582

引用

页码：689 / 689

页数：1

共 7 条

[1] Impact of fremanezumab on headache intensity and duration of remaining migraine attacks: PEARL 3rd interim analysis
Tassorelli, C.
Mitsikostas, D.
Amin, F.
Kokturk, P.
Schankin, C.
Sahin, G.
Pozo-Rosich, P.
Dorman, P.
Nezadal, T.
Poole, A.
Martins, I.
Sumelahti, M.
Krasenbaum, L.
Ahn, A.
Akcicek, H.
Ashina, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 690 - 690
[2] Real-world effectiveness & safety of fremanezumab in migraine: 3rd interim analysis of the pan-European PEARL study
Ashina, M.
Mitsikostas, D.
Amin, F.
Kokturk, P.
Schankin, C.
Sahin, G.
Pozo-Rosich, P.
Dorman, P.
Nezadal, T.
Poole, A.
Martins, I.
Sumelahti, M.
Campos, V. Ramirez
Ning, X.
Lyras, L.
Tassorelli, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 149 - 150
[3] Real-World effectiveness and safety of fremanezumab in migraine: 3rd interim analysis of the pan-european PEARL study
Ashina, M.
Mitsikostas, D. D.
Amin, F. Mohammad
Kokturk, P.
Schankin, C. J.
Sahin, G.
Pozo-Rosich, P.
Dorman, P.
Nezadal, T.
Poole, A. Christine
Martins, I. Pavao
Sumelahti, M. L.
Campos, V. Ramirez
Ning, X.
Lyras, L.
Tassorelli, C.
JOURNAL OF HEADACHE AND PAIN, 2024, 25
[4] Real-world effectiveness of switching to fremanezumab from other CGRP pathway targeting mAbs: PEARL 3rd interim analysis
Ashina, M.
Mitsikostas, D.
Amin, F.
Kokturk, P.
Schankin, C.
Sahin, G.
Pozo-Rosich, P.
Dorman, P.
Nezadal, T.
Poole, A.
Martins, I.
Sumelahti, M.
Campos, V. Ramirez
Ning, X.
Akcicek, H.
Tassorelli, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 371 - 372
[5] POOLED ANALYSIS OF CARDIOVASCULAR SAFETY WITH FREMANEZUMAB TREATMENT IN PATIENTS WITH MIGRAINE AND CONCOMITANT CARDIOVASCULAR MEDICATION OR TRIPTAN USE AT BASELINE
Coppola, Gianluca
Ning, Xiaoping
Kessler, Yoel
Cohen, Joshua M.
Du, Evelyn
Barbanti, Piero
CEPHALALGIA, 2020, 40 : 83 - 83
[6] Pooled Analysis of Safety and Tolerability with Fremanezumab Treatment in Patients with Migraine and Baseline Cardiovascular Medication or Concomitant Triptan Use
Coppola, Gianluca
Ning, Xiaoping
Kessler, Yoel
Cohen, Joshua M.
Du, Evelyn
Barbanti, Piero
ANNALS OF NEUROLOGY, 2020, 88 : S155 - S155
[7] Interim analysis of adjunctive perampanel as 2nd or 3rd anti-seizure medication from the observational PERPRISE study
Steinhoff, B.
Golmann, T.
Winter, Y.
EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 626 - 626

← 1 →